Inventor · disambiguated record
Kuei-Lin Lu
Also filed as: LU KUEI LIN
4 granted patents·3 pending applications·0 citations·filing 2012–2017
54Inventor score
Files withINST NUCLEAR ENERGY RES ATOMIC ENERGY COUNCIL EXECUTIVE YUAN ROC2LIU SHOW-WEN2INER AEC EXECUTIVE YUAN1INSTITUTE OF NUCLEAR ENERGY RES ATOMIC ENERGY COUNCIL EXECUTIVE YUAN P R C1LU KUEI-LIN1
Top patents by PatentIndex Score
7 records- 0152US9981953B1Contrast agent precursor and method for preparing the sameINER AEC EXECUTIVE YUAN·Filed 2017·Granted May 29, 2018·0 cites·8 claims
- 0252US8877943B2Radiotracer precursor and method for preparing the sameLIU SHOW-WEN·Filed 2012·Granted Nov 4, 2014·0 cites·9 claims
- 0350US9714220B2Tetradentate organic ligand H3-MN-16Bn containing long alkyl group, precursor thereof, and method for preparing the sameINST NUCLEAR ENERGY RES ATOMIC ENERGY COUNCIL EXECUTIVE YUAN ROC·Filed 2015·Granted Jul 25, 2017·0 cites·10 claims
- 0447US9150602B2Precursor used for labeling hepatorcyte receptor and containing trisaccharide and diamide demercaptide ligand, method for preparing the same, radiotracer and pharmaceutical composition of the sameLIU SHOW-WEN·Filed 2012·Granted Oct 6, 2015·0 cites·19 claims
- 0544US2014066609A1Synthesis method of glyco-drug radiotracer precursorLU KUEI-LIN·Filed 2012·Application pending·0 cites
- 0634US2017115259A1High performance liquid chromatography method for analyzing imaging agent, precursor of imaging agent, or intermediate of imaging agentINST NUCLEAR ENERGY RES ATOMIC ENERGY COUNCIL EXECUTIVE YUAN ROC·Filed 2015·Application pending·0 cites
- 0731US2018059072A1High performance liquid chromatography method for analysis of mn diagnostic and therapeutic ligand and precursorINSTITUTE OF NUCLEAR ENERGY RES ATOMIC ENERGY COUNCIL EXECUTIVE YUAN P R C·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kuei-Lin Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →